242 related articles for article (PubMed ID: 29148063)
1. Studies on the curcumin phospholipid complex solidified with Soluplus
Wang J; Wang L; Zhang L; He D; Ju J; Li W
J Pharm Pharmacol; 2018 Feb; 70(2):242-249. PubMed ID: 29148063
[TBL] [Abstract][Full Text] [Related]
2. Application of Soluplus to Improve the Flowability and Dissolution of Baicalein Phospholipid Complex.
Fan J; Dai Y; Shen H; Ju J; Zhao Z
Molecules; 2017 May; 22(5):. PubMed ID: 28492487
[TBL] [Abstract][Full Text] [Related]
3. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
4. [Solidification of magnolol phospholipid complex with polyvingypyrrolidone].
Dai YH; Wang M; Ju JM; Zhang ZH
Zhongguo Zhong Yao Za Zhi; 2016 Jun; 41(12):2250-2254. PubMed ID: 28901068
[TBL] [Abstract][Full Text] [Related]
5. Enhancing solubility and bioavailability of coenzyme Q
Lamichhane S; Seo JE; Keum T; Noh G; Bashyal S; Cho SW; Lee EH; Lee S
Arch Pharm Res; 2022 Jan; 45(1):29-37. PubMed ID: 35128573
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of curcumin-loaded self-assembled micelles.
Wang LL; He DD; Wang SX; Dai YH; Ju JM; Zhao CL
Drug Dev Ind Pharm; 2018 Apr; 44(4):563-569. PubMed ID: 29148846
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of Oral Bioavailability of Curcumin by a Novel Solid Dispersion System.
Hu L; Shi Y; Li JH; Gao N; Ji J; Niu F; Chen Q; Yang X; Wang S
AAPS PharmSciTech; 2015 Dec; 16(6):1327-34. PubMed ID: 25804949
[TBL] [Abstract][Full Text] [Related]
8. Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.
Zhang Z; Chen Y; Deng J; Jia X; Zhou J; Lv H
Int J Pharm; 2014 Apr; 465(1-2):306-16. PubMed ID: 24456672
[TBL] [Abstract][Full Text] [Related]
9. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
[TBL] [Abstract][Full Text] [Related]
10. Third-generation solid dispersion combining Soluplus and poloxamer 407 enhances the oral bioavailability of resveratrol.
Vasconcelos T; Prezotti F; Araújo F; Lopes C; Loureiro A; Marques S; Sarmento B
Int J Pharm; 2021 Feb; 595():120245. PubMed ID: 33484925
[TBL] [Abstract][Full Text] [Related]
11. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
12. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
[TBL] [Abstract][Full Text] [Related]
13. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
15. A phospholipid complex to improve the oral bioavailability of flavonoids.
Wang H; Cui Y; Fu Q; Deng B; Li G; Yang J; Wu T; Xie Y
Drug Dev Ind Pharm; 2015; 41(10):1693-703. PubMed ID: 25496311
[TBL] [Abstract][Full Text] [Related]
16. Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.
Liu P; Zhou JY; Chang JH; Liu XG; Xue HF; Wang RX; Li ZS; Li CS; Wang J; Liu CZ
Drug Des Devel Ther; 2020; 14():2959-2975. PubMed ID: 32801637
[TBL] [Abstract][Full Text] [Related]
17. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier.
Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
Drug Dev Ind Pharm; 2015 May; 41(5):772-9. PubMed ID: 24669978
[TBL] [Abstract][Full Text] [Related]
18. Novel rifampicin-phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation.
Singh C; Bhatt TD; Gill MS; Suresh S
Int J Pharm; 2014 Jan; 460(1-2):220-7. PubMed ID: 24188983
[TBL] [Abstract][Full Text] [Related]
19. Preparation and pharmacokinetic evaluation of curcumin solid dispersion using Solutol® HS15 as a carrier.
Seo SW; Han HK; Chun MK; Choi HK
Int J Pharm; 2012 Mar; 424(1-2):18-25. PubMed ID: 22226878
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability.
Parikh A; Kathawala K; Song Y; Zhou XF; Garg S
Drug Deliv Transl Res; 2018 Oct; 8(5):1389-1405. PubMed ID: 29845380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
